Financial Instruments and Significant Concentrations (Tables)

6 Months Ended

Dec. 31, 2025

Financial Instruments and Significant Concentrations

Schedule of financial assets measured at fair value on a recurring basis

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicates the fair value hierarchy classification as of December 31, 2025 and June 30, 2025 (in thousands):



	Fair Value Measurement of Assets as of December 31, 2025
	Total		Level 1		Level 2		Level 3
Cash and cash equivalents:
Money market funds	$	8,126	$	8,126	$	—	$	—
Marketable debt securities:
Corporate commercial paper		40,452		—		40,452		—
U.S. Government agencies		1,270		—		1,270		—
U.S. Government treasuries		1,750		—		1,750		—
Corporate notes and bonds		77,522		—		77,522		—
Total	$	129,120	$	8,126	$	120,994	$	—


	Fair Value Measurement of Assets as of June 30, 2025
	Total		Level 1		Level 2		Level 3
Cash and cash equivalents:
Money market funds	$	86,059	$	86,059	$	—	$	—
Corporate commercial paper		1,000		—		1,000		—
U.S. Government treasuries		1,996		—		1,996		—
Marketable debt securities:
Corporate commercial paper		16,588		—		16,588		—
U.S. Government agencies		5,445		—		5,445		—
U.S. Government treasuries		1,484		—		1,484		—
Corporate notes and bonds		50,234		—		50,234		—
Total	$	162,806	$	86,059	$	76,747	$	—

Schedule of changes in the fair value of the company's embedded derivative liability, fair value, level 3 inputs

The following table sets forth changes in the fair value of the Company’s embedded derivative liability for which fair value was determined on a recurring basis for the six months ended December 31, 2025 and 2024 (in thousands):


	2025		2024
Fair value, beginning of period	$	468	$	468
Changes in fair value		15		9
Fair value, end of period	$	483	$	477

Rezolute, Inc. 10-Q